{"entity":{"type":"insider","cik":"0001314240","url":"/insider/0001314240","json_url":"/insider/0001314240.json","name":"Zacks Leslie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2006-11-02","last":"2008-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Zacks Leslie","source":"filing","n_filings":7,"first_seen":"2006-11-02","last_seen":"2008-05-19"}],"transactions":[{"id":2774566,"accession":"0001104659-08-034341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-08-034341","line_url":"/filing/0001104659-08-034341#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001314240","owner_name":"Zacks Leslie","owner_display_name":"Zacks Leslie","owner_url":"/insider/0001314240","role":"Officer (EVP/Chief Legal Compl. Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Legal Compl. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Legal Compl. Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":21.71,"price_display":"21.71","price_state":"stated","total_value":35278.75,"total_display":"35,278.75","total_whole":"35,279","shares_owned_after":71675.0,"shares_owned_after_display":"71,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-19","filed_date":"2008-05-19","scope":"insider"},{"id":2468365,"accession":"0001104659-08-004640","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-08-004640","line_url":"/filing/0001104659-08-004640#line-2","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001314240","owner_name":"Zacks Leslie","owner_display_name":"Zacks Leslie","owner_url":"/insider/0001314240","role":"Officer (EVP, Chief LegalCompl. Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief LegalCompl. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief LegalCompl. Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1875.0,"shares_display":"1,875","price_per_share":23.8615,"price_display":"23.86","price_state":"stated","total_value":44740.3125,"total_display":"44,740.31","total_whole":"44,740","shares_owned_after":71425.0,"shares_owned_after_display":"71,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-24","filed_date":"2008-01-25","scope":"insider"},{"id":2468359,"accession":"0001104659-08-004640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-08-004640","line_url":"/filing/0001104659-08-004640#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001314240","owner_name":"Zacks Leslie","owner_display_name":"Zacks Leslie","owner_url":"/insider/0001314240","role":"Officer (EVP, Chief LegalCompl. Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief LegalCompl. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief LegalCompl. Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3075.0,"shares_display":"3,075","price_per_share":22.4361,"price_display":"22.44","price_state":"stated","total_value":68991.0075,"total_display":"68,991.01","total_whole":"68,991","shares_owned_after":73300.0,"shares_owned_after_display":"73,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-23","filed_date":"2008-01-25","scope":"insider"},{"id":7819787,"accession":"0001104659-07-087927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-07-087927","line_url":"/filing/0001104659-07-087927#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001314240","owner_name":"Zacks Leslie","owner_display_name":"Zacks Leslie","owner_url":"/insider/0001314240","role":"Officer (EVP, Chief Legal & Compliance)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal & Compliance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal & Compliance","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":22.75,"price_display":"22.75","price_state":"stated","total_value":85312.5,"total_display":"85,312.50","total_whole":"85,313","shares_owned_after":76375.0,"shares_owned_after_display":"76,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-07","filed_date":"2007-12-10","scope":"insider"},{"id":7819715,"accession":"0001104659-07-079329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-07-079329","line_url":"/filing/0001104659-07-079329#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001314240","owner_name":"Zacks Leslie","owner_display_name":"Zacks Leslie","owner_url":"/insider/0001314240","role":"Officer (EVP of Legal & Administration)","role_mark":"O","role_mark_label":"Officer (EVP of Legal & Administration)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Legal & Administration","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":25.25,"price_display":"25.25","price_state":"stated","total_value":157812.5,"total_display":"157,812.50","total_whole":"157,813","shares_owned_after":48125.0,"shares_owned_after_display":"48,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":8485234,"accession":"0001104659-07-061872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-07-061872","line_url":"/filing/0001104659-07-061872#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001314240","owner_name":"Zacks Leslie","owner_display_name":"Zacks Leslie","owner_url":"/insider/0001314240","role":"Officer (EVP of Legal & Administration)","role_mark":"O","role_mark_label":"Officer (EVP of Legal & Administration)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Legal & Administration","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2704.0,"shares_display":"2,704","price_per_share":23.88,"price_display":"23.88","price_state":"stated","total_value":64571.52,"total_display":"64,571.52","total_whole":"64,572","shares_owned_after":54375.0,"shares_owned_after_display":"54,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-08","filed_date":"2007-08-13","scope":"insider"},{"id":7397338,"accession":"0001104659-07-005000","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-07-005000","line_url":"/filing/0001104659-07-005000","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001314240","owner_name":"Zacks Leslie","owner_display_name":"Zacks Leslie","owner_url":"/insider/0001314240","role":"Officer (VP of Legal & Administration)","role_mark":"O","role_mark_label":"Officer (VP of Legal & Administration)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Legal & Administration","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1671.0,"shares_display":"1,671","price_per_share":23.86527827648115,"price_display":"23.87","price_state":"stated","total_value":39878.88,"total_display":"39,878.88","total_whole":"39,879","shares_owned_after":47079.0,"shares_owned_after_display":"47,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-01-24","filed_date":"2007-01-26","scope":"insider","n_lines":2},{"id":3937067,"accession":"0001104659-06-070722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-06-070722","line_url":"/filing/0001104659-06-070722#line-1","is_derivative":false,"issuer_cik":"0001106773","issuer_name":"SCIELE PHARMA, INC.","issuer_ticker":"SCRX","issuer_name_source":null,"issuer_url":"/issuer/0001106773","owner_cik":"0001314240","owner_name":"Zacks Leslie","owner_display_name":"Zacks Leslie","owner_url":"/insider/0001314240","role":"Officer (Vice President)","role_mark":"O","role_mark_label":"Officer (Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":21.7695,"price_display":"21.77","price_state":"stated","total_value":136059.375,"total_display":"136,059.38","total_whole":"136,059","shares_owned_after":33750.0,"shares_owned_after_display":"33,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-31","filed_date":"2006-11-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001106773","name":"SCIELE PHARMA, INC.","url":"/issuer/0001106773","role":"Officer (EVP/Chief Legal Compl. Officer)","n_filings":7,"first_seen":"2006-11-02","last_seen":"2008-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001314240","retrieved_at":"2026-08-22T07:33:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}